Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05926765

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Led by MeiraGTx, LLC · Updated on 2026-02-02

276

Participants Needed

33

Research Sites

181 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will assess the efficacy and safety of bilateral intra-parotid administration of AAV2-hAQP1 in adults with Grade 2 or Grade 3 radiation-induced late xerostomia.

CONDITIONS

Official Title

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Completed beam radiation therapy for head and neck cancer at least 3 years prior to the first screening visit
  • No history of recurrent head and neck cancer, parotid gland cancer, or a second primary cancer, except for treated basal cell or squamous cell carcinoma of the skin or in situ cervical carcinoma
  • An unstimulated whole saliva flow rate (mL/min) >0 (at least one drop of saliva in the collection tube)
  • A stimulated whole saliva flow rate (mL/min) within a specified range after mechanical stimulation by chewing
  • Average screening Xerostomia-specific Questionnaire (XQ) Total Score at or above a specified threshold
  • No evidence of head and neck cancer by negative otolaryngology exam and CT scan of head, neck, and chest with contrast (or recent MRI, PET, or FDG-PET within 6 months)
  • Either discontinued prescription sialagogue therapy or elected not to start it
  • Participants using pilocarpine or cevimeline must stop at least 2 weeks before screening and agree to avoid during the study
  • Stable dose for at least one month prior to screening of any medications known to affect salivary output for underlying medical conditions
Not Eligible

You will not qualify if you...

  • History of recurrent head and neck cancer, parotid gland cancer, or a second primary cancer, except for treated basal cell or squamous cell carcinoma of the skin or in situ cervical carcinoma
  • History of systemic autoimmune disease affecting salivary glands (e.g., Sjogren's disease)
  • Use of systemic immunosuppressive medications within 4 weeks before screening (topical, inhaled, or intranasal corticosteroids allowed)
  • Active Epstein-Barr virus infection (positive anti-VCA IgM)
  • Active Hepatitis C virus infection
  • Human immunodeficiency virus (HIV) infection
  • Diagnosis of myasthenia gravis
  • Personal or family history of acute or chronic angle-closure glaucoma or at increased risk for it
  • Known allergy or sensitivity to glycopyrrolate
  • Current smokers or those who smoked or vaped with tobacco additives within the past 3 years
  • Current or recent (past 3 years) alcohol misuse as defined by local guidelines
  • Poorly controlled diabetes with hemoglobin A1c >7%

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 33 locations

1

Banner MD Anderson Cancer Center

Gilbert, Arizona, United States, 85234

Actively Recruiting

2

City of Hope

Duarte, California, United States, 91010

Actively Recruiting

3

Miami Cancer Institute at Baptist Health South Florida

Miami, Florida, United States, 33176

Actively Recruiting

4

University of Iowa

Iowa City, Iowa, United States, 52242

Actively Recruiting

5

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21231

Actively Recruiting

6

Tufts University School of Dental Medicine

Boston, Massachusetts, United States, 02111

Actively Recruiting

7

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02120

Actively Recruiting

8

Henry Ford Health

Detroit, Michigan, United States, 48202

Actively Recruiting

9

University of Missouri

Columbia, Missouri, United States, 65212

Actively Recruiting

10

Washington University - St. Louis

St Louis, Missouri, United States, 63110

Actively Recruiting

11

Erie County Medical Center

Buffalo, New York, United States, 14215

Actively Recruiting

12

UNC-Chapel Hill

Chapel Hill, North Carolina, United States, 27514

Actively Recruiting

13

Atrium Health

Charlotte, North Carolina, United States, 28203

Actively Recruiting

14

Penn State

Hershey, Pennsylvania, United States, 17033

Actively Recruiting

15

Alleghany General Hospital

Pittsburgh, Pennsylvania, United States, 15212

Actively Recruiting

16

Johnson City Medical Center

Johnson City, Tennessee, United States, 37604

Actively Recruiting

17

UT Southwestern Medical Center

Dallas, Texas, United States, 75390

Actively Recruiting

18

Houston Methodist

Houston, Texas, United States, 77030

Actively Recruiting

19

Shirley and Jim Fielding Northeast Cancer Centre - Health Sciences North

Greater Sudbury, Ontario, Canada, P3E 5J1

Actively Recruiting

20

Hopital Fleurimont, CIUSSS de l'Estrie-CHUS

Québec, Canada, J1H 5HE

Actively Recruiting

21

Princess Margaret Cancer Centre

Toronto, Canada, M5G 2C4

Actively Recruiting

22

CIUSSS-MCQ (Trois-Rivières, QC)

Trois-Rivières, Canada, G8Z 3R9

Actively Recruiting

23

Addenbrooke's Hospital

Cambridge, United Kingdom

Actively Recruiting

24

Cardiff and Vale NHS Trust - Head & Neck Services

Cardiff, United Kingdom, CF14 4XW

Actively Recruiting

25

Ninewells Hospital & Medical School

Dundee, United Kingdom, DD1 9SY

Actively Recruiting

26

Glasgow Royal Infirmary

Glasgow, United Kingdom, LS2 9LU

Actively Recruiting

27

Leeds Dental Institute

Leeds, United Kingdom, LS2 9LU

Actively Recruiting

28

Western General

London, United Kingdom, EH4 2XU

Actively Recruiting

29

Guys Hospital

London, United Kingdom, SE1 9RT

Actively Recruiting

30

The Royal Marsden

London, United Kingdom, SW3 6JJ

Actively Recruiting

31

University College London Hospitals NHS Foundation Trust

London, United Kingdom, WC1E 6DG

Actively Recruiting

32

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom, NG7 2UH

Actively Recruiting

33

York Hospital

York, United Kingdom, YO31 8HE

Actively Recruiting

Loading map...

Research Team

M

MeiraGTx Clinical Project Manager

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

6

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here